Brief: Immunovia: Positive Results From Model-Development Study

Immunovia AB (publ)

22/04/2024 07:34

April 22 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA ANNOUNCES POSITIVE RESULTS FROM THE
MODEL-DEVELOPMENT
STUDY FOR ITS NEXT-GENERATION PANCREATIC CANCER DETECTION TEST
    * NEXT-GENERATION PANCREATIC CANCER TEST ACHIEVED PRIMARY,
SECONDARY ENDPOINTS IN MODEL-DEVELOPMENT STUDY
    * WILL NOW MOVE TO A SECOND PHASE OF MODEL DEVELOPMENT
STUDY,
EXPECTED TO BE COMPLETED IN 6 - 8 WEEKS
    * IN Q4 CO WILL CONDUCT LARGE CLINICAL VALIDATION STUDY
SETTING
STAGE FOR A U.S. LAUNCH IN 2025

Source text for Eikon:  ID:nWkr6bmJRG 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))